1. Home
  2. RAPP vs GAIN Comparison

RAPP vs GAIN Comparison

Compare RAPP & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPP
  • GAIN
  • Stock Information
  • Founded
  • RAPP 2022
  • GAIN 2005
  • Country
  • RAPP United States
  • GAIN United States
  • Employees
  • RAPP N/A
  • GAIN N/A
  • Industry
  • RAPP
  • GAIN Finance: Consumer Services
  • Sector
  • RAPP
  • GAIN Finance
  • Exchange
  • RAPP Nasdaq
  • GAIN Nasdaq
  • Market Cap
  • RAPP 439.4M
  • GAIN 519.9M
  • IPO Year
  • RAPP 2024
  • GAIN 2005
  • Fundamental
  • Price
  • RAPP $16.05
  • GAIN $14.02
  • Analyst Decision
  • RAPP Strong Buy
  • GAIN Hold
  • Analyst Count
  • RAPP 2
  • GAIN 2
  • Target Price
  • RAPP $35.00
  • GAIN $13.50
  • AVG Volume (30 Days)
  • RAPP 177.9K
  • GAIN 136.6K
  • Earning Date
  • RAPP 08-07-2025
  • GAIN 08-12-2025
  • Dividend Yield
  • RAPP N/A
  • GAIN 15.66%
  • EPS Growth
  • RAPP N/A
  • GAIN N/A
  • EPS
  • RAPP N/A
  • GAIN 1.78
  • Revenue
  • RAPP N/A
  • GAIN $93,662,000.00
  • Revenue This Year
  • RAPP N/A
  • GAIN $5.34
  • Revenue Next Year
  • RAPP N/A
  • GAIN $5.29
  • P/E Ratio
  • RAPP N/A
  • GAIN $7.90
  • Revenue Growth
  • RAPP N/A
  • GAIN 7.28
  • 52 Week Low
  • RAPP $6.43
  • GAIN $11.42
  • 52 Week High
  • RAPP $29.74
  • GAIN $15.34
  • Technical
  • Relative Strength Index (RSI)
  • RAPP N/A
  • GAIN 45.39
  • Support Level
  • RAPP N/A
  • GAIN $13.83
  • Resistance Level
  • RAPP N/A
  • GAIN $14.22
  • Average True Range (ATR)
  • RAPP 0.00
  • GAIN 0.18
  • MACD
  • RAPP 0.00
  • GAIN -0.01
  • Stochastic Oscillator
  • RAPP 0.00
  • GAIN 38.00

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

Share on Social Networks: